Inflammatory bowel diseases: time of diagnosis, environmental factors, clinical course, and management – a follow-up study in a private inflammatory bowel disease center (2003–2017)
DB Cury,1 R Oliveira,2 MS Cury3 1Inflammatory Bowel Disease Center, Scope Clinic, Campo Grande/MS, Brazil; 2Biostatistics, UNESP, Botucatu, São Paulo, SP, Brazil; 3Advanced Endoscopy Center, Scope Clinic, Campo Grande/MS, Brazil Background: The governmental program of Brazilian Unified Na...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2019
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/b0af2a451cfb4288a2579f7be31cdcaf |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:b0af2a451cfb4288a2579f7be31cdcaf |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:b0af2a451cfb4288a2579f7be31cdcaf2021-12-02T02:42:53ZInflammatory bowel diseases: time of diagnosis, environmental factors, clinical course, and management – a follow-up study in a private inflammatory bowel disease center (2003–2017)1178-7031https://doaj.org/article/b0af2a451cfb4288a2579f7be31cdcaf2019-05-01T00:00:00Zhttps://www.dovepress.com/inflammatory-bowel-diseases-time-of-diagnosis-environmental-factors-cl-peer-reviewed-article-JIRhttps://doaj.org/toc/1178-7031DB Cury,1 R Oliveira,2 MS Cury3 1Inflammatory Bowel Disease Center, Scope Clinic, Campo Grande/MS, Brazil; 2Biostatistics, UNESP, Botucatu, São Paulo, SP, Brazil; 3Advanced Endoscopy Center, Scope Clinic, Campo Grande/MS, Brazil Background: The governmental program of Brazilian Unified National Health System has already published studies on the incidence of inflammatory bowel diseases (IBD), but up until now, there have been no epidemiological studies in private centers in Brazil. However, these diseases tend to affect people from a higher socioeconomic class, mainly in the capital of MS state that has the third highest GDP in Brazil. Objectives: The aim was to analyze an observational, descriptive study of an IBD database in a private center including: the side, behavior of the disease and medical management, the association of extra-intestinal manifestations, and the main clinical symptoms which led to the investigation and diagnosis of IBD. Patients and methods: A cohort study was developed in which data of all patients with IBD were analyzed with SPSS software in a constructed electronic database. Results: Of 329 patients, 212 (64.4%) had Crohn’s disease (CD) and 117 (35.6%) had ulcerative colitis (UC). Average age at diagnosis of CD was 36.19 (±14.33) and of UC was 41.61 (±15.37). An amount of 50.05% of the patients with CD and 72.7% (P<0.001) with UC were female. We have observed that concerning the first symptoms, diahrrea and blood feces corresponded to 70% in UC while in CD 50% of the patients presented diahrrea with blood feces, loss of weight corresponded to 50% and only diahrrea 25%. (P<0.001). Anti-TNFs corresponded to 56.2% being more frequent in CD 0.001%. CD patients used biologic therapy and antibiotics more frequently than those with UC. In conclusion, IBD is also frequent in private health care centers in Brazil; women are most affected. Symptoms such as diarrhea and bleeding, as well as diarrhea and weight loss, must be taken as warning signs to investigate for inflammatory disease. The use of biologic therapies is frequent in referral centers when patients have severe disease. Keywords: Crohn’s disease, ulcerative Colitis, alert symptoms, behavior, anti-TNF, extra-intestinal manifestationsCury DBOliveira RCury MSDove Medical Pressarticleinflammatory bowel diseasemain symptomsanti-TNFextraintestinal manifestationsPathologyRB1-214Therapeutics. PharmacologyRM1-950ENJournal of Inflammation Research, Vol Volume 12, Pp 127-135 (2019) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
inflammatory bowel disease main symptoms anti-TNF extraintestinal manifestations Pathology RB1-214 Therapeutics. Pharmacology RM1-950 |
| spellingShingle |
inflammatory bowel disease main symptoms anti-TNF extraintestinal manifestations Pathology RB1-214 Therapeutics. Pharmacology RM1-950 Cury DB Oliveira R Cury MS Inflammatory bowel diseases: time of diagnosis, environmental factors, clinical course, and management – a follow-up study in a private inflammatory bowel disease center (2003–2017) |
| description |
DB Cury,1 R Oliveira,2 MS Cury3 1Inflammatory Bowel Disease Center, Scope Clinic, Campo Grande/MS, Brazil; 2Biostatistics, UNESP, Botucatu, São Paulo, SP, Brazil; 3Advanced Endoscopy Center, Scope Clinic, Campo Grande/MS, Brazil Background: The governmental program of Brazilian Unified National Health System has already published studies on the incidence of inflammatory bowel diseases (IBD), but up until now, there have been no epidemiological studies in private centers in Brazil. However, these diseases tend to affect people from a higher socioeconomic class, mainly in the capital of MS state that has the third highest GDP in Brazil. Objectives: The aim was to analyze an observational, descriptive study of an IBD database in a private center including: the side, behavior of the disease and medical management, the association of extra-intestinal manifestations, and the main clinical symptoms which led to the investigation and diagnosis of IBD. Patients and methods: A cohort study was developed in which data of all patients with IBD were analyzed with SPSS software in a constructed electronic database. Results: Of 329 patients, 212 (64.4%) had Crohn’s disease (CD) and 117 (35.6%) had ulcerative colitis (UC). Average age at diagnosis of CD was 36.19 (±14.33) and of UC was 41.61 (±15.37). An amount of 50.05% of the patients with CD and 72.7% (P<0.001) with UC were female. We have observed that concerning the first symptoms, diahrrea and blood feces corresponded to 70% in UC while in CD 50% of the patients presented diahrrea with blood feces, loss of weight corresponded to 50% and only diahrrea 25%. (P<0.001). Anti-TNFs corresponded to 56.2% being more frequent in CD 0.001%. CD patients used biologic therapy and antibiotics more frequently than those with UC. In conclusion, IBD is also frequent in private health care centers in Brazil; women are most affected. Symptoms such as diarrhea and bleeding, as well as diarrhea and weight loss, must be taken as warning signs to investigate for inflammatory disease. The use of biologic therapies is frequent in referral centers when patients have severe disease. Keywords: Crohn’s disease, ulcerative Colitis, alert symptoms, behavior, anti-TNF, extra-intestinal manifestations |
| format |
article |
| author |
Cury DB Oliveira R Cury MS |
| author_facet |
Cury DB Oliveira R Cury MS |
| author_sort |
Cury DB |
| title |
Inflammatory bowel diseases: time of diagnosis, environmental factors, clinical course, and management – a follow-up study in a private inflammatory bowel disease center (2003–2017) |
| title_short |
Inflammatory bowel diseases: time of diagnosis, environmental factors, clinical course, and management – a follow-up study in a private inflammatory bowel disease center (2003–2017) |
| title_full |
Inflammatory bowel diseases: time of diagnosis, environmental factors, clinical course, and management – a follow-up study in a private inflammatory bowel disease center (2003–2017) |
| title_fullStr |
Inflammatory bowel diseases: time of diagnosis, environmental factors, clinical course, and management – a follow-up study in a private inflammatory bowel disease center (2003–2017) |
| title_full_unstemmed |
Inflammatory bowel diseases: time of diagnosis, environmental factors, clinical course, and management – a follow-up study in a private inflammatory bowel disease center (2003–2017) |
| title_sort |
inflammatory bowel diseases: time of diagnosis, environmental factors, clinical course, and management – a follow-up study in a private inflammatory bowel disease center (2003–2017) |
| publisher |
Dove Medical Press |
| publishDate |
2019 |
| url |
https://doaj.org/article/b0af2a451cfb4288a2579f7be31cdcaf |
| work_keys_str_mv |
AT curydb inflammatoryboweldiseasestimeofdiagnosisenvironmentalfactorsclinicalcourseandmanagementndashafollowupstudyinaprivateinflammatoryboweldiseasecenter2003ndash2017 AT oliveirar inflammatoryboweldiseasestimeofdiagnosisenvironmentalfactorsclinicalcourseandmanagementndashafollowupstudyinaprivateinflammatoryboweldiseasecenter2003ndash2017 AT curyms inflammatoryboweldiseasestimeofdiagnosisenvironmentalfactorsclinicalcourseandmanagementndashafollowupstudyinaprivateinflammatoryboweldiseasecenter2003ndash2017 |
| _version_ |
1718402244974477312 |